tiprankstipranks
Trending News
More News >
Advertisement

AIVL - ETF AI Analysis

Compare

Top Page

AIVL

WisdomTree U.S. AI Enhanced Value Fund (AIVL)

Rating:71Outperform
Price Target:
$125.00
The WisdomTree U.S. AI Enhanced Value Fund (AIVL) demonstrates solid overall quality, driven by strong contributions from holdings like Medtronic (MDT) and Exxon Mobil (XOM). Medtronic stands out for its robust financial performance and growth prospects, while Exxon Mobil benefits from strategic initiatives and balanced valuation. However, weaker holdings such as Nisource (NI) and Bank of America (BAC), which face financial performance concerns and technical challenges, slightly weigh on the fund's rating. A notable risk is the fund's exposure to stocks with high valuations, which could limit upside potential in certain market conditions.
Positive Factors
Strong Sector Diversification
The ETF is spread across multiple sectors, including financials, technology, and health care, reducing reliance on any single industry.
Solid Performance from Key Holdings
Several top holdings, such as Medtronic and Teledyne Technologies, have delivered strong year-to-date performance, contributing positively to the fund.
Reasonable Expense Ratio
The ETF charges a moderate expense ratio, which is competitive and helps investors retain more of their returns.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, offering limited exposure to international markets and diversification.
Underperforming Holdings
Some top holdings, such as Comcast and US Bancorp, have experienced weak year-to-date performance, which could drag on overall returns.
Moderate Asset Base
The fund's assets under management are relatively modest, which could limit liquidity and scalability compared to larger ETFs.

AIVL vs. SPDR S&P 500 ETF (SPY)

AIVL Summary

The WisdomTree U.S. AI Enhanced Value Fund (AIVL) is an ETF that uses artificial intelligence to find undervalued U.S. companies with strong growth potential. It focuses on value stocks across various sectors, including financials, technology, and healthcare. Some well-known companies in the fund include Bank of America and Exxon Mobil. Investors might consider AIVL for its unique approach to combining AI with value investing, offering a chance to diversify their portfolio with stocks that could be poised for appreciation. However, since it’s heavily focused on U.S. value stocks, its performance can fluctuate with market conditions and economic cycles.
How much will it cost me?The WisdomTree U.S. AI Enhanced Value Fund (AIVL) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This expense ratio is slightly higher than average for ETFs because it uses an actively managed, AI-enhanced strategy to identify value stocks, which requires more resources compared to passively managed funds. It may be worth the cost if you value its innovative approach to investing.
What would affect this ETF?The AIVL ETF, with its focus on U.S. value stocks and AI-driven strategy, could benefit from a strong U.S. economy, rising corporate earnings, and advancements in AI technology that enhance stock selection. However, it may face challenges from rising interest rates, which could pressure value stocks, or sector-specific risks in financials and technology, which are its largest exposures. Regulatory changes or economic slowdowns could also negatively impact its performance.

AIVL Top 10 Holdings

The WisdomTree U.S. AI Enhanced Value Fund (AIVL) leans heavily into financials and technology, with names like US Bancorp and Intercontinental Exchange shaping its trajectory. US Bancorp is showing mixed signals, with profitability offset by revenue concerns, while Intercontinental Exchange is grappling with bearish momentum despite strong management strategies. On the brighter side, Medtronic and RTX are rising stars in healthcare and industrials, respectively, thanks to robust growth and strategic positioning. Comcast, however, is dragging the fund with lagging broadband performance. Overall, the fund’s U.S.-focused, value-driven approach offers a blend of steady and struggling names across diverse sectors.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
RTX3.36%$12.67M$237.88B46.64%
75
Outperform
US Bancorp3.21%$12.11M$72.89B-3.04%
74
Outperform
Boston Scientific3.19%$12.04M$149.02B19.70%
79
Outperform
Bank of America3.11%$11.73M$392.79B26.80%
66
Neutral
Exxon Mobil3.06%$11.53M$488.95B-1.79%
79
Outperform
Nisource3.04%$11.45M$20.10B19.82%
66
Neutral
Intercontinental Exchange2.99%$11.26M$85.02B-4.72%
68
Neutral
Medtronic2.95%$11.12M$116.69B1.93%
71
Outperform
Teledyne Technologies2.78%$10.48M$24.31B13.71%
72
Outperform
Comcast2.77%$10.45M$100.87B-37.44%
69
Neutral

AIVL Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
113.82
Negative
100DMA
113.00
Negative
200DMA
110.35
Positive
Market Momentum
MACD
-0.08
Positive
RSI
43.80
Neutral
STOCH
9.69
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AIVL, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 114.01, equal to the 50-day MA of 113.82, and equal to the 200-day MA of 110.35, indicating a neutral trend. The MACD of -0.08 indicates Positive momentum. The RSI at 43.80 is Neutral, neither overbought nor oversold. The STOCH value of 9.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AIVL.

AIVL Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$378.35M0.38%
71
Outperform
$711.76M0.13%
68
Neutral
$533.85M0.40%
75
Outperform
$452.09M0.29%
73
Outperform
$256.29M0.60%
70
Outperform
$207.25M0.50%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AIVL
WisdomTree U.S. AI Enhanced Value Fund
112.83
5.47
5.10%
VFVA
Vanguard U.S. Value Factor ETF
LSVD
LSV Disciplined Value ETF
QVAL
Alpha Architect U.S. Quantitative Value ETF
BUSA
Brandes U.S. Value ETF
GVLU
Gotham 1000 Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement